Program By Day

7:00 AM-7:55 AM Poster Session B: Advance Care Planning; Caregiver Support; Coordination and Continuity of Care; End-of-Life Care; Models of Care; Survivorship; and Symptom Biology, Assessment and Management
with Complimentary Continental Breakfast
7:55 AM-8:45 AM Welcome and Keynote Lecture

Rajesh V. Lalla, DDS, PhD
University of Connecticut Health
Welcome of the Day

Suleika Jaouad
Patient Advocate
Making the Most of a Life, Interrupted: A Young Adult Perspective on Cancer
8:50 AM-9:45 AM

General Session 4: Caregiver and Patient Narratives at the End

Charles L. Loprinzi, MD, FASCO—Chair
Mayo Clinic, Rochester

Andrew S. Epstein, MD—Chair
Memorial Sloan Kettering Cancer Center

Charles L. Loprinzi, MD, FASCO
Mayo Clinic, Rochester
Introduction

Stay With Me Awhile

Mary E. Johnson
Playwright

Catherine McBride
Original Cast Member, Stay With Me Awhile

Thom Nustad
Original Cast Member, Stay With Me Awhile

Lori Carrell, PhD, Chancellor University of Minnesota Rochester
Original Cast Member, Stay With Me Awhile

Panel Question and Answer

9:45 AM-10:15 AM Break
10:15 AM-11:30 AM Oral Abstract Session B

Andrew S. Epstein, MD—Chair
Memorial Sloan Kettering Cancer Center

Yolanda D. Tseng, MD—Chair
University of Washington

Abstract 19: Disparities in length of goals of care conversations between oncologists and patients with advanced cancer.
First Author: Cardinale B. Smith, MD, PhD

Ian N. Olver, MD, PhD, FRACP
University of South Australia
Discussion

Abstract 20: Willingness to bear adversity and beliefs about the curability of advanced cancer.
First Author: Kah Poh Loh

Abstract 21: Perceiving hope from oncologists and prognostic understanding and treatment planning.
First Author: Login George, PhD

Jennifer W. Mack, MD
Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center
Discussion

Panel Question and Answer
11:30 AM-1:00 PM Poster Session B: Advance Care Planning; Caregiver Support; Coordination and Continuity of Care; End-of-Life Care; Models of Care; Survivorship; and Symptom Biology, Assessment and Management
with Complimentary Boxed Lunch
11:45 AM-12:45 PM

Trainee and Early-Career Networking Luncheon
Information on the Luncheon and confirmed faculty listings can be found here.

1:00 PM-2:30 PM General Session 5: Immunotherapeutic Quandaries

Kavita V. Dharmarajan, MD—Chair
Icahn School of Medicine at Mount Sinai

Marybeth Singer, MS, ANP-BC, AOCN—Chair
Tufts Medical Center

Silvia Formenti, MD
New York-Presbyterian Hospital
Combining Radiotherapy and Immunotherapy

Abstract 184: Immunotherapy-related toxicities: More common than originally reported?
First Author: Elizabeth Jane Cathcart-Rake, MD

Allison Betof Warner, MD, PhD
Memorial Sloan Kettering Cancer Center
Incorporating Clinical Practice Guidelines for Managing Immune-Related Adverse Events

Betty Ferrell, PhD, RN, FAAN, FPCN, CHPN
City of Hope National Medical Center
Navigating Quality of Life and Transitions in the Era of Immunotherapy

Panel Question and Answer
2:30 PM-3:00 PM Break
3:00 PM-4:30 PM

General Session 6: Show Me the Money! Financial Toxicity During Treatment and Beyond

Mary K. Buss, MD, MPH—Chair
Beth Israel Deaconess Medical Center/Harvard Medical School

Candice A. Johnstone, MD, MPH—Chair
Medical College of Wisconsin
Case Introduction

Tatiana M. Prowell, MD
US Food and Drug Administration and Johns Hopkins Kimmel Comprehensive Cancer Center
Stakeholder Perspectives on the Cost of Cancer Care

Ian N. Olver, MD, PhD, FRACP
University of South Australia
Patient Decision Making When Facing Financial Toxicity: What Drives Preferences?

Yousuf Zafar, MD, MHS
Duke University Medical Center
Interventions to Improve Transparency and Communication About Costs in Cancer Care

Panel Question and Answer